Skip to main content
spacbrain

BCAR merger with Exascale Labs Inc.

Exascale Labs is an asset-light, software-defined AI infrastructure provider (United States)Revenue $13M (LTM 3/31/2026) as reported.

StatusClosed (deSPAC)
Announced deal value$500M

Announced 11 January 2026.

Shareholder vote29 July 2026
Ticker after closingXLAB

The symbol the combined company is expected to trade under.

IndustryTechnology — AI Infrastructure / GPU-as-a-Service (asset-light neocloud)

Business Combination Agreement dated 2026-01-11 (announced via 8-K, filed 2026-01-13). S-4 effective 2026-07-01; DEFM14A filed 2026-07-07. Shareholders APPROVED the Business Combination at the EGM on 2026-07-29 (8-K Item 5.07): FOR 24,503,325 / AGAINST 1,120,108 / ABSTAIN 35,000. PubCo = Exascale Labs Holdings Inc., expected to trade Nasdaq: XLAB / XLABW. ~$12M left in trust after redemptions. Distinct from DBCA whose earlier Exascale S-4 was withdrawn (RW).


Structure & dilution

SEC-primary terms

The headline number ignores the shares that did not pay $10 — the founder promote, PIPE stock and warrants. This is the same deal with all equity claims counted.

Deal structureSEC-primary — BCA 8-K / S-4 / DEFM14A
Headline$500MvsEffective$912M+82% dilution

Effective equity counts every claim on the post-close company at $10.00 — rollover, public shares, the founder promote and the PIPE. The headline counts only the target.

Min-cash condition
$5M
Sponsor promote
30%
Pro-forma shares
91.2M
Exchange ratio
Each Company Share converted into Purchaser Class B Shares equal to the Per Share Merger Consideration divided by $10.00, each Class B share carrying twenty (20) votesmore ▾
PIPE structure:
No PIPE secured. The 424B3 states that as of its date neither BCAR nor Exascale had secured financing for the Minimum Cash Financing, which may take the form of cash, trust cash, a PIPE, an equity linmore ▾
Minimum cash: $5M from the trust together with other financing, after transaction expenses.
Outside date: 1 September 2026 — the contractual long-stop for closing. It is not a redemption deadline and confers no right to cash.
Lock-up:
For purpose of this Agreement, the “ Lock-up Period ” means with respect to the Lock-up Shares, the period commencing on the Closing Date and ending on the earlier of (1) the date that is six (6) months after the Closing Date or (2) the date on which Purchaser Surviving Corporation completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the stockholders of Purchaser Surviving Corporation having the right to exchange their Purchaser Surviving Corporation Shares for cash, securities or other propertymore ▾
What it is being valued atSEC-primary — the filed capitalisation table

Three different numbers are all called the deal value

They are not the same fact, and only the last one is what a valuation multiple may be struck on.

Pre-money equity value of the target$500M

What Exascale Labs Inc. on its own is valued at, before a dollar of the SPAC's trust or the PIPE reaches it. This is the price agreed for the business itself.

Pro-forma equity value of the combined company$912M

assumes 0% redemptions

Every share of the combined company, marked at the reference price, once the deal closes — the business PLUS the cash that arrives with it. This is the figure press headlines quote, and it is bigger than the business for that reason alone.

Cash on the balance sheet at close$280M

assumes 0% redemptions

Money the transaction puts INTO the company. It is counted inside the equity value above, which is why it comes straight back out to reach the figure below — nobody pays a revenue multiple for a bank balance.

Pro-forma enterprise value$632M

The combined company net of that cash — what the buyers are paying for the BUSINESS. Every multiple below is struck on this figure and on nothing else.

What that price is, per dollar of sales

Enterprise value ÷ LTM 3/31/2026 revenue48.2×

$632M ÷ $13.1M of LTM 3/31/2026 revenue. $1 of Exascale Labs Inc.'s 2026 reported sales is being bought for $48.20.

Enterprise value ÷ 2026E revenue31.6×

2026E projection — a forecast the company made about itself, not money it has earned

$632M ÷ $20M of 2026E revenue. $1 of Exascale Labs Inc.'s 2026 PROJECTED sales is being bought for $31.60.

Enterprise value ÷ EBITDA — not shown

No EBITDA figure for Exascale Labs Inc. appears in any filing we hold, so no EV/EBITDA multiple is shown. We have not inferred one from a margin assumption — a multiple built on an assumed margin measures the assumption, not the company.

What qualifies these figures

  • The equity and cash figures above assume NOBODY REDEEMS — the filing's own assumption, and the most favourable one available to it. Public shareholders in this market frequently redeem most of a trust; at a higher rate both figures fall together and the enterprise value the multiples are struck on does not move.
  • The announced headline of $500M and the filed pro-forma equity value of $912M are not the same number. Both are recorded as stated; we have not reconciled them for you.
  • Every multiple above is struck on a PROJECTION the company made about itself in a marketing document, not on money it has earned. Listed peers are measured on revenue they actually booked, so any comparison flatters this deal by exactly as much as the forecast is optimistic.

All figures above are stated in EX-99.1 investor deck (425)0001829126-26-004062opens on sec.gov in a new tab

THIS DECK STATES THE TABLE TWICE, AT 0% AND AT 100% REDEMPTIONS, AND THE PAIR IS WORTH MORE THAN EITHER. At 0%: "91.2 Shares Outstanding (Millions) $10.0 Share Price $912.0 Implied Equity Value ($280.0) (-) Pro Forma Net Cash $632.0 Implied Enterprise Value". At 100%: "63.2 Shares Outstanding (Millions) $10.0 Share Price $632.0 Implied Equity Value $0 (-) Pro Forma Net Cash $632.0 Implied Enterprise Value". The equity value falls by $280.0M and the cash falls by the same $280.0M, and BOTH slides are headed "Exascale pre - money valuation of $500M ‒ Transaction implies $632M pro forma enterprise value". The figures stored are the 0% scenario, matching the assumption the other filed tables in this set use; the 100% scenario is quoted here rather than dropped. The multiple this page strikes is on the $632M enterprise value, which is the same number under both. One more thing the deck says about all of it: "The valuation described herein was determined through negotiations between the parties and was not based on a third - party valuation or fairness opinion."

Why headline and effective values differ is covered in headline vs effective deal value, in plain English.


The target: Exascale Labs Inc.

from DEFM14A

The business actually being bought — described from SEC primary filings, with projections labelled as projections.

Exascale Labs is an asset-light, software-defined AI infrastructure provider. Its revenue-generating business is GPU-as-a-Service (GaaS): it resells reserved and on-demand access to high-performance GPU compute that it sources from THIRD-PARTY data centers (it owns no core hardware), plus GPU cluster management and optimization services for AI data centre operators. It also markets modular data centre, high-density liquid cooling, HVDC power and energy-storage designs, but the filing states these have NOT YET GENERATED ANY REVENUE. Exascale IS revenue-generating - $7.0m in FY2025 and $10.6m in the nine months to 31 March 2026 - but it is a very small, loss-making, thin-margin reseller: gross margin is only ~16%, it has 10 full-time employees (4 in the US, 6 remote in Singapore), and it has negative shareholders' equity of $(20.9)m against a $500m deal value. It has never been profitable, with an accumulated deficit of $21.1m at 31 March 2026.

SectorTechnology — AI Infrastructure / GPU-as-a-Service (asset-light neocloud)
HeadquartersHouston, United States

Founded 2022.

Revenue$13M (LTM 3/31/2026)

A reported actual.

Employees10

source: 0001829126-26-007326opens on sec.gov in a new tab

Exascale Labs Inc. — every SPAC that has bid for it, and its listed peers


Expensive or cheap?

vs 2 listed peers

A price only means something next to what the same kind of business costs on the stock market. This divides what the buyers are paying by what Exascale Labs Inc. actually sells, and sets the answer against its closest listed comparables — or says plainly when that cannot be done.

SpacBrain’s read on the price

Priced above its listed peers

The deal values Exascale Labs Inc. at $632M, or 48.2× the LTM 3/31/2026 actual revenue it actually reported. That is 1.4× what the market pays for its closest listed peers (median 33.49×) — an expensive price.

What the buyers are paying for the whole company$632M

Pro-forma enterprise value as filed.

Divided by what the company actually sells in a year$13.1M

LTM 3/31/2026 — a reported actual.

= what this deal pays for every dollar of those sales48.2×

48.2× LTM 3/31/2026 actual revenue. Put another way: $1 of its annual sales is being bought for $48.20.

What the stock market pays for its closest listed peers33.49×

$1 of their sales costs $33.49 on the open market. Median of 2 listed companies we judged a true comparable, which individually run from 13.79× to 53.18×. Their share prices are from 15 August 2026, not today.

What qualifies this number

  • AZIO, SHAZ, AIB, BTBT, WYFI, ALP, SUPX, TSSI, QMLS, VIP, BIRD have no revenue to divide by, so they are shown but left out of the peer median.
  • APLD, IREN, CORZ, WULF, GLXY shown for context only — not close enough to move the median.
The 18 listed companies it is measured against, and why
  • CRWV13.79× revenue

    CoreWeave is the pure-play GPU-as-a-Service neocloud and the closest business-model match - reserved and on-demand GPU compute for LLM training and inference. Caveat: CoreWeave's revenue is roughly three orders of magnitude larger, so it is a model peer, not a scale peer.

  • AZIOno revenue multiple

    Direct comp: Auto, Truck & Motorcycle Parts (NEC); micro-cap ($2m); shares gpu, compute, density, infrastructure, data, modular with the target's own description; no forward EV/Sales published — counted as a peer, excluded from the median.

  • NBIS53.18× revenue

    Nebius Group is an AI-cloud/GPU-compute provider selling the same reserved and on-demand GPU capacity to AI workloads; identical revenue model, again dramatically larger scale.

  • SHAZno revenue multiple

    Operational comp: IT Services & Consulting (NEC); micro-cap ($23m); shares gpu, compute, data, infrastructure, storage, high with the target's own description; forward EV/Sales 10.7x.

  • APLD23.65× revenuecontext only — left out of the median

    Applied Digital sells HPC/AI data centre capacity and GPU cloud services, the nearest listed name in the AI-infrastructure mid-cap bucket - but it OWNS and builds its data centres, the opposite of Exascale's asset-light no-hardware model.

  • AIBno revenue multiple

    Operational comp: IT Services & Consulting (NEC); shares compute, density, data, centers, infrastructure, high with the target's own description; forward EV/Sales 11.5x.

  • IREN23.44× revenuecontext only — left out of the median

    IREN operates AI cloud services on GPU fleets alongside bitcoin mining; relevant as an AI-compute revenue comparable but it owns its own power and data centre infrastructure, so the cost structure and capital intensity are not comparable.

  • BTBTno revenue multiple

    Operational comp: Cryptocurrency Mining; small-cap ($612m); shares gpu, cooling, data, centers, liquid, asset with the target's own description; forward EV/Sales 6.9x.

  • CORZ20.43× revenuecontext only — left out of the median

    Core Scientific provides colocation and hosting for HPC/AI compute; a valuation reference for AI compute capacity but asset-heavy and far larger, with a fundamentally different margin profile.

  • WYFIno revenue multiple

    Operational comp: IT Services & Consulting (NEC); small-cap ($605m); shares gpu, data, cooling, infrastructure, centers, high with the target's own description; forward EV/Sales 8.2x.

  • WULF65.11× revenuecontext only — left out of the median

    TeraWulf is converting mining sites into AI/HPC hosting capacity; useful as an AI-infrastructure sentiment comparable only - it is an infrastructure owner, not an asset-light compute reseller.

  • ALPno revenue multiple

    Operational comp: IT Services & Consulting (NEC); micro-cap ($7m); shares gpu, compute, infrastructure, data, hardware, service with the target's own description; no forward EV/Sales published — counted as a peer, excluded from the median.

  • GLXY0.15× revenuecontext only — left out of the median

    Galaxy Digital's Helios data centre business is a listed AI-compute landlord comparable; included for completeness but the business mix (digital asset trading and asset management) makes it a poor read-across.

  • SUPXno revenue multiple

    Operational comp: IT Services & Consulting (NEC); micro-cap ($224m); shares density, cooling, high, infrastructure, singapore, liquid with the target's own description; no forward EV/Sales published — counted as a peer, excluded from the median.

  • TSSIno revenue multiple

    Operational comp: IT Services & Consulting (NEC); micro-cap ($204m); shares data, modular, centers, hardware, infrastructure, party with the target's own description; forward EV/Sales 1.1x.

  • QMLSno revenue multiple

    Operational comp: IT Services & Consulting (NEC); shares gpu, compute, infrastructure, power, small, software with the target's own description; no forward EV/Sales published — counted as a peer, excluded from the median.

  • VIPno revenue multiple

    Operational comp: IT Services & Consulting (NEC); micro-cap ($23m); shares infrastructure, data, power, high, centers, performance with the target's own description; no forward EV/Sales published — counted as a peer, excluded from the median.

  • BIRDno revenue multiple

    Operational comp: IT Services & Consulting (NEC); micro-cap ($25m); shares cluster, infrastructure, hardware, performance, designs, not with the target's own description; no forward EV/Sales published — counted as a peer, excluded from the median.

Which companies count as comparable is our judgement, written out above so you can disagree with it. The median is what these shares happened to trade at on the date given — not a price anyone is offering for this deal.


In plain English

No floor / floorlessthe cash guarantee is gone — the price is unprotected

A SPAC's downside protection is not the cash in trust; it is your right to demand that cash. Once the redemption window closes, the cash stays with the company and the share can trade anywhere.

Dilutionhow much of the company new shares take from you

Sponsor promote, PIPE shares, warrants and rights all issue stock that did not pay $10 for it. The headline deal value is before that; the effective value is after.

Pro-forma equitywhat the company is valued at once the deal closes

The combined company's equity value assuming the announced terms and the redemptions that have actually happened.

De-SPACthe day the SPAC becomes the real company

The shares stop being a claim on a pot of cash and start being equity in an operating business. Roughly 80% of recent de-SPACs traded below $10 within a year.

Outside datethe contractual long-stop for closing the deal

A deadline between the SPAC and its target, not between the SPAC and you. It confers no right to cash, which is exactly why it must never be counted as a redemption window.